Company News

Croda Acquires IRB

Active ingredients obtained by plant stem cell culture.

Croda International Plc has completed the acquisition of IRB (Istituto di Ricerche Biotecnologiche SpA.), the Italy-based world leader in the emerging market of active ingredients obtained by plant stem cell culture.


IRB holds a unique position in the market with the widest range of plant cell lines characterised by specific markers and the ability to manufacture titrated plant extracts through its exclusive biotechnological process. Croda strengthens its investment in innovative and sustainable personal care ingredients by combining IRB’s distinctive production method with Sederma’s extensive performance testing and claim substantiation know-how.

Croda, via the Sederma brand, will bring plant cell culture biotechnology to the customers as the leading, unprecedented technology for delivering proven efficacy as well as true sustainability, with consumer demands in mind.

More info: www.croda.com, www.sederma.fr or www.irbtech.com

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters